We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

16 hedge funds and large institutions have $108M invested in Nightstar Therapeutics plc American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

25% less capital invested

Capital invested by funds: $143M → $108M (-$35.2M)

45% less funds holding

Funds holding: 2916 (-13)

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
16
Holders Change
-13
Holders Change %
-44.83%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
3
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$46.9M +$16M +892,611 +35%
RG
2
Redmile Group
California
$21.9M +$62.9K +3,500 +0.2%
PHS
3
PFM Health Sciences
California
$12.8M +$8.36M +464,966 +90%
NMC
4
NEA Management Company
Maryland
$9.37M
Franklin Resources
5
Franklin Resources
California
$4.45M
Ameriprise
6
Ameriprise
Minnesota
$4.41M +$385K +21,446 +7%
TCP
7
Tourbillon Capital Partners
New York
$2.24M +$359K +19,952 +13%
EIM
8
Essex Investment Management
Massachusetts
$1.77M +$2.43M +134,965 New
CIP
9
Chartwell Investment Partners
Pennsylvania
$1.46M -$1.73M -96,518 -46%
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$1.31M
USAA
11
United Services Automobile Association
Texas
$939K +$551K +30,658 +81%
PCM
12
Prelude Capital Management
New York
$448K -$578K -32,164 -48%
PIM
13
Partner Investment Management
California
$132K +$84.3K +4,688 +88%
UBS Group
14
UBS Group
Switzerland
$14K -$26K -1,445 -58%
Macquarie Group
15
Macquarie Group
Australia
$8K +$10.8K +600 New
PA
16
Parallel Advisors
California
$3K +$4.69K +261 New
BlackRock
17
BlackRock
New York
-$6.24M -325,000 Closed
ACM
18
Asymmetry Capital Management
California
-$2.5M -130,007 Closed
ACP
19
Acuta Capital Partners
California
-$1.92M -100,000 Closed
SFM
20
Sphera Funds Management
Israel
-$1.73M -90,000 Closed
NFA
21
Nationwide Fund Advisors
Ohio
-$1.2M -62,300 Closed
Millennium Management
22
Millennium Management
New York
-$875K -45,573 Closed
FCM
23
Farallon Capital Management
California
-$774K -40,300 Closed
Goldman Sachs
24
Goldman Sachs
New York
-$515K -26,800 Closed
Tudor Investment Corp
25
Tudor Investment Corp
Connecticut
-$430K -22,400 Closed

NITE Hedge Fund Activity: Q4 2017 in Review

16 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q4 2017, worth a combined $108M — down 25% from $143M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of NITE and 3 opened new positions — a net loss of 13 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Wellington Management Group, adding an estimated $16M. The largest seller was BlackRock, exiting entirely with an estimated $6.24M sold.

  • 16 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q4 2017, down from 29 in Q3 2017.
  • Funds reported $108M of Nightstar Therapeutics plc American Depositary Shares stock for Q4 2017, down 25% quarter-over-quarter.
  • 3 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q4 2017 and 16 closed out, a net change of -13 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q4 2017 was Wellington Management Group, an estimated $16M added.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q4 2017 was BlackRock, an estimated $6.24M sold.

Based on aggregated 13F filings for Q4 2017.